|
Vitamin D Analogs as Adjuvants in Chemotherapy
|
2R01CA044722-18A2
|
$224,795
|
$112,398
|
STUDZINSKI, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$52,763
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
2P50CA100632-06
|
$2,300,000
|
$1,173,000
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
3P50CA100632-06S1
|
$40,163
|
$20,483
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$611
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$59,947
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S4
|
$2,630,152
|
$52,603
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S5
|
$61,584
|
$1,232
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
5R37CA072614-12
|
$309,845
|
$309,845
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
The role of tonic signal-input in stable gene profiles
|
5K01CA113367-03
|
$149,580
|
$29,916
|
ROOSE, JEROEN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
|
1K08CA134649-01
|
$127,170
|
$63,585
|
LI, QING
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
The Role of BCR/ABL in Regulating DNA Repair
|
5R01CA100885-05
|
$246,470
|
$24,647
|
CARROLL, MARTIN
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S1
|
$91,948
|
$3,678
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S2
|
$49,383
|
$1,975
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S3
|
$83,152
|
$3,326
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-15
|
$5,084,061
|
$203,362
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The RB Gene Family in Cancer Initiation
|
5R01CA114102-03
|
$277,675
|
$55,535
|
SAGE, JULIEN
|
STANFORD UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
$896
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-33
|
$3,753,703
|
$37,537
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
5P01CA023766-30
|
$2,959,846
|
$591,969
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
Z01 SC 010288
|
$942,078
|
$47,104
|
Fowler, Daniel
|
CCR (NCI)
|
|
Telomere Shortening and Stem Cell Maintenance
|
5K08CA118416-03
|
$140,010
|
$140,010
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting Leukemic Stem Cells
|
1R01CA138211-01
|
$350,261
|
$175,131
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
Z01 BC 010782
|
$365,279
|
$91,320
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Studies of BCR/ABL Leukemogenesis in Mice
|
5R01CA090576-09
|
$286,110
|
$286,110
|
Van Etten, Richard
|
TUFTS MEDICAL CENTER
|
|
Stanford University Cancer Center
|
3P30CA124435-02S1
|
$80,833
|
$1,617
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-02
|
$1,572,967
|
$31,459
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Src Kinases in Ph+ Lymphoblastic Leukemia
|
5R01CA114199-04
|
$284,832
|
$284,832
|
LI, SHAOGUANG
|
JACKSON LABORATORY
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S1
|
$115,875
|
$11,588
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S2
|
$247,200
|
$24,720
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S3
|
$92,700
|
$9,270
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S4
|
$76,478
|
$7,648
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-24
|
$4,005,660
|
$400,566
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome
|
5R01CA120272-03
|
$263,700
|
$263,700
|
Chen, Jing
|
EMORY UNIVERSITY
|
|
Signal Transduction of Type I Interferons in Malignant Cells
|
5R01CA077816-11
|
$301,177
|
$301,177
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY
|
|
Role of RNA Binding Proteins in BCR/ABL Leukemogenesis
|
2R01CA095512-05A1
|
$250,821
|
$250,821
|
Perrotti, Danilo
|
OHIO STATE UNIVERSITY
|
|
Role of Redox Dependent Signaling in Leukemia
|
5R01CA115811-02
|
$292,600
|
$292,600
|
CHANDRA, JOYA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Role of MN1-TEL and MN1 in Leukemogenesis
|
5R01CA072996-12
|
$333,189
|
$333,189
|
GROSVELD, GERARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Role of Lipocalin 24p3 in Apoptosis and Leukemia
|
5R01CA115817-03
|
$252,065
|
$252,065
|
GREEN, MICHAEL
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
2R01CA095684-05
|
$321,555
|
$321,555
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$148,414
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Randomized study of combined epigenetic therapy
|
5R01CA121104-02
|
$292,600
|
$292,600
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Program on Molecular and Cellular Mechanisms of Tumorigenesis
|
5P01CA016519-33
|
$1,872,378
|
$187,238
|
BOEKE, Jef
|
JOHNS HOPKINS UNIVERSITY
|
|
Predictors of Adult Leukemia
|
5R01CA107143-04
|
$494,244
|
$247,122
|
Ross, Julie
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Phosphatase Targets of Lenalidomide in Myelodysplastic Syndrome
|
1R01CA131076-01
|
$466,719
|
$466,719
|
LIST, ALAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Pathogenesis & Therapy of 8p11 Leukemia/Lymphoma
|
5R01CA105043-05
|
$316,836
|
$316,836
|
Van Etten, Richard
|
TUFTS MEDICAL CENTER
|
|
Opposing Roles for MEK/ERK in Differentiation & Leukemia
|
3R01CA108904-04S1
|
$41,931
|
$8,386
|
JOHNSON, DANIEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Opposing Roles for MEK/ERK in Differentiation & Leukemia
|
5R01CA108904-04
|
$249,963
|
$49,993
|
JOHNSON, DANIEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Oncogene-Induced Evasion from Apoptosis
|
5R01CA105306-04
|
$318,352
|
$318,352
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
OHSU Cancer Institute
|
3P30CA069533-12S1
|
$69,612
|
$3,481
|
DRUKER, BRIAN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $31,297,852
|